PT Prodia Widyahusada Tbk (IDX:PRDA)

Market Cap	2.18T -8.5%
Revenue (ttm)	2.28T +1.3%
Net Income	206.79B -23.5%
EPS	227.25 -21.2%
Shares Out	889.78M
PE Ratio	10.78
Forward PE	8.56
Dividend	172.93 (7.06%)
Ex-Dividend Date	May 8, 2025

Volume	125,900
Average Volume	432,670
Open	2,470.00
Previous Close	2,480.00
Day's Range	2,450.00 - 2,510.00
52-Week Range	2,290.00 - 3,010.00
Beta	-0.20
RSI	51.98
Earnings Date	Apr 30, 2026

About PT Prodia Widyahusada Tbk

PT Prodia Widyahusada Tbk provides clinical laboratory services primarily in Indonesia. The company offers laboratory, genomic, non-laboratory, and panel test services. It also operates Prodia specialty clinics; and provides vaccination, doctor consultation, and home services. It serves to individuals, doctors, and corporate and partnerships. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Prodia Widyahusada Tbk operates as a subsidiary of PT Prodia Utama.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1973
• Employees: 2,947
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PRDA

Financial Performance

In 2025, PT Prodia Widyahusada Tbk's revenue was 2.28 trillion, an increase of 1.31% compared to the previous year's 2.25 trillion. Earnings were 206.79 billion, a decrease of -23.47%.